Life Sciences Accounting & Reporting Congress 2026

The Life Sciences Accounting & Reporting Congress 2026 addresses accounting, financial reporting, and regulatory compliance challenges in life sciences, with emphasis on ESG disclosure, digital transformation, and strategic financial leadership.

Key Topics

• ESG reporting and sustainability disclosure requirements
• AI and digital transformation in life sciences finance
• Inflation Reduction Act (IRA) financial impact and compliance
• SEC and FASB regulatory updates and compliance
• Clinical trial financial management and accounting
• Revenue recognition and GTN (Gross-to-Net) methodologies
• Clinical-to-commercial transition accounting
• Supply chain financial strategies and risk management
• Strategic capital deployment and M&A frameworks
• Internal audit and SOX compliance excellence
• Chief Finance Officer (CFO) leadership
• Accounting and reporting for small and large pharmaceutical, biotech and medical device manufacturers

Who should Attend

Attendees with job titles such as:

• Controllers
• CAO/CFO
• Financial Reporting
• Accounting
• Finance
• Auditing
• Revenue
• Financial Planning & Analysis
• Transactions
• Forecasting
• Contracts
• Risk and Controls
• Business Decision Support
• Business/Corporate Development
• Consultant
• Financial Auditor
• Software Provider